Efpeglenatide
AMPLITUDE-O
Sanofi · Phase 3 · Terminated · Enrollment 4076
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Placebo | T2D only | n/r | 4 | n/r | n/r |
| Efpeglenatide 4 mg | T2D only | 4 mg | 4 | n/r | n/r |
| Efpeglenatide 6 mg | T2D only | 6 mg | 4 | n/r | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Efpeglenatide
Sanofi · Phase 3 · Terminated · Enrollment 4076
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Placebo | T2D only | n/r | 4 | n/r | n/r |
| Efpeglenatide 4 mg | T2D only | 4 mg | 4 | n/r | n/r |
| Efpeglenatide 6 mg | T2D only | 6 mg | 4 | n/r | n/r |